Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Shigella sonnei vaccine - GSK

Next Previous
Drug Profile

Shigella sonnei vaccine - GSK

Alternative Names: 1790GAHB vaccine; GSK-3536852; GSK-3536852A; GSK-3902986A; GVGH Shigella sonnei 1790GAHB vaccine

Latest Information Update: 28 Apr 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Novartis
  • Developer GSK
  • Class Bacterial vaccines; Conjugate vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Shigella infections

Most Recent Events

  • 28 Apr 2023 Shigella sonnei vaccine is still in phase II trials for Shigella infections (Prevention) in USA (IM) (GSK pipeline, April 2023)
  • 10 Nov 2022 Phase I development for Shigella infections (Prevention) is ongoing United Kingdom (GlaxoSmithKline pipeline, November 2022)
  • 29 Apr 2020 Discontinued - Phase-I for Shigella infections (Prevention) in United Kingdom (Intradermal) (GlaxoSmithKline pipeline, April 2020)
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top